title: In reply to Gondi and Mehta.
authors: Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
authors: Jiayi
authors: J
authors: Huang
authors: Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
authors: Clifford G
authors: CG
authors: Robinson
authors: Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
authors: Shahed N
authors: SN
authors: Badiyan
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine